Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Lipocalin / cytosolic fatty-acid binding protein family protein | 0.0258 | 0.4384 | 0.4384 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0187 | 0.296 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FAK protein kinase | 0.0539 | 1 | 1 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Echinococcus granulosus | protein tyrosine kinase | 0.0533 | 0.9874 | 1 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Schistosoma mansoni | tyrosine kinase | 0.0533 | 0.9874 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0187 | 0.296 | 0.5 |
Echinococcus multilocularis | protein tyrosine kinase | 0.0533 | 0.9874 | 1 |
Loa Loa (eye worm) | lipocalin/cytosolic fatty-acid binding protein family protein | 0.0258 | 0.4384 | 0.4384 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0174 | 0.2697 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0039 | 0 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Reduction of prostrate weight in orally dosed immature rat | ChEMBL. | 17337185 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.